MURPHY ANDREW J Insider Trading -- Recent SEC Form 4 Transactions
MURPHY ANDREW J (CIK 1796226) reported 54 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-18). Recent activity: Buy REGN (17,000 shares), Sell REGN (340 shares), Sell REGN (93 shares), Sell REGN (74 shares), Sell REGN (298 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Buy | 17,000 | $6.5M |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 340 | $327,882 |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 93 | $88,321 |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 74 | $70,345 |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 298 | $283,622 |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 220 | $209,605 |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 671 | $639,926 |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 11,989 | $11.5M |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 313 | $299,065 |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 346 | $331,018 |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 202 | $193,421 |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 244 | $233,818 |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 506 | $485,482 |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 257 | $246,887 |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 584 | $561,487 |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 295 | $283,996 |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 255 | $245,718 |
| 2026-11-18 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 313 | $298,743 |
| 2026-11-05 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 1,054 | $0 |
| 2026-10-15 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 24 | $18,196 |
| 2026-10-15 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 12,853 | $9.7M |
| 2026-10-15 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 6 | $4,523 |
| 2026-10-15 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 35 | $26,457 |
| 2026-10-15 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Sell | 16 | $12,123 |
| 2026-10-15 | REGENERON PHARMACEUTICALS, INC. (REGN) | Co-Chief Scientific Officer | Buy | 17,000 | $6.5M |
Source: SEC Form 4 filings · as of 2026-11-18